Company Filing History:
2 out of 119 
2 out of 48 
Years Active: 2012-2013
Title: Frank Brietling: Innovator in Tumor Treatment
Introduction
Frank Brietling is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of medical research, particularly in the treatment of tumors. With a total of 2 patents, his work focuses on innovative approaches to cancer therapy.
Latest Patents
Brietling's latest patents include the development of a treatment for tumors using a specific anti-L1 antibody. The present invention relates to the anti-L1 monoclonal antibody 9.3, as well as to related antibodies or binding molecules. This invention emphasizes the uses of these antibodies, especially in tumor treatment.
Career Highlights
Throughout his career, Frank Brietling has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Medigene AG. His work in these institutions has allowed him to advance his research and contribute to significant medical advancements.
Collaborations
Some of his notable coworkers include Daniela Kelm and Peter Altevogt. Their collaboration has likely played a role in the development of innovative solutions in cancer treatment.
Conclusion
Frank Brietling's contributions to tumor treatment through his patents and collaborations highlight his importance in the field of medical research. His innovative approaches continue to pave the way for advancements in cancer therapy.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.